Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.3 USD | +0.41% | -0.67% | +509.29% |
09/05 | Landos Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02/04 | North American Morning Briefing : Stocks Seen -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+509.29% | 6.94Cr | |
+44.48% | 5.4TCr | |
+43.57% | 4.2TCr | |
-0.86% | 4.19TCr | |
-7.59% | 2.84TCr | |
+12.30% | 2.64TCr | |
-21.83% | 1.9TCr | |
+7.15% | 1.3TCr | |
+29.40% | 1.23TCr | |
+25.15% | 1.22TCr |
- Stock Market
- Equities
- LABP Stock
- News Landos Biopharma, Inc.
- Landos Biopharma Enters Research Collaboration to Investigate Effects of NX-13 on Epithelial Cells